Burza, Sakib <br/><br/>
Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India.  [electronic resource] 

 -  PLoS neglected tropical diseases  2014 
 - e2536 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1935-2735 
<br/><br/><label>Standard No.: </label>10.1371/journal.pntd.0002536  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intravenous<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Amphotericin B--administration & dosage<br/>Antiprotozoal Agents--administration & dosage<br/>Child<br/>Child, Preschool<br/>Cohort Studies<br/>Female<br/>Humans<br/>India--epidemiology<br/>Infant<br/>Leishmaniasis, Visceral--drug therapy<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Retrospective Studies<br/>Risk Factors<br/>Young Adult